Cornerstone Wealth Management, LLC Kazia Therapeutics LTD Transaction History

Cornerstone Wealth Management, LLC

  • $1.39 Billion
  • Q3 2024

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2018

Oct 19, 2018
SELL
$3.05 - $3.9 $14,164 - $18,111
-4,644 Closed
0 $0
Q2 2018

Jul 20, 2018
BUY
$2.9 - $5.9 $13,467 - $27,399
4,644 New
4,644 $1.43 Million

Others Institutions Holding KZIA

# of Institutions
21
Shares Held
2.13M
Call Options Held
93.2K
Put Options Held
0
View Full List

About KAZIA THERAPEUTICS LTD

KZIA Quotes by TradingView
  • Ticker KZIA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 15,111,300
  • Market Cap $47M
  • Description
  • Kazia Therapeutics Limited, an oncology-focused biotechnology company, develops anti-cancer drugs. Its lead development candidate is Paxalisib, a small molecule, brain-penetrant inhibitor of the PI3K/Akt/mTor pathway, which is developed as a potential therapy for glioblastoma. It is also developing EVT801, an investigational new drug for various...
More about KZIA
Track This Portfolio

Track Cornerstone Wealth Management, LLC Portfolio

Follow Cornerstone Wealth Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cornerstone Wealth Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cornerstone Wealth Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email